Partner Jennifer O’Farrell provides commentary on Actavis UK Ltd and others v Eli Lilly and Company decision

Relevant sectors

Aerospace

• Commercial aviation
• Defence and security
• Space and satellites
• Unmanned aerial vehicles

Artificial intelligence and machine learning

Automotive

• Autonomous vehicles
• Electric vehicles
• Engines

Biotechnology

• Antibody engineering
• Antibody manufacture and formulation
• Bioinformatics
• Biosimilars
• Drug delivery
• Gene editing (e.g. CRISPR)
• Genomic and molecular tools and methods
• GM crops
• Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
• Next generation sequencing
• Nucleic acid synthesis
• Personalised medicine/disease biomarkers
• Recombinant protein production and purification
• Stem cell therapies
• Supplementary protection certificates (SPCs)
• Synthetic biology
• Therapeutic antibodies
• Vaccinology (e.g. viral vectors; mRNA vaccines)
• Women’s health products

Chemicals

• Agrochemicals
• Catalysts
• Dispersions and colloids
• Lubricants
• Polymers and plastics

Communications and networks

• Cloud computing
• Internet of things (IOT)
• Oceanography, marine
• Wired and wireless networks

Computing and software

• Artificial intelligence and machine learning
• Bioinformatics
• Blockchain and distributed ledgers
• Communications and networks
• Computer games
• Data and software security, cryptography and digital rights management (DRM)
• Data management and storage, databases and data compression
• Digital assistants, virtual assistants and software agents
• Fintech and adtech
• Machine vision
• Metaverse, virtual reality (VR) and augmented reality (AR)
• Motor capture
• Multimedia, audio/video processing and animation
• Natural language processing
• Quantum computing
• Robotic process automation
• Search engines
• Signal processing
• Software applications and systems, mobile applications, user interfaces

Consumer goods and retail

• Anti-counterfeit devices
• Beauty
• Fashion
• Health, fitness and sport
• Household goods
• Luxury goods
• Moda
• Retail

Electronics and electrical devices

• Computer and IT architecture and system design
• Medical devices
• Optics
• Restaurants and bars
• Robotics
• Scientific instruments
• Semiconductor devices
• Testing systems, control systems, signal processing
• Travel and leisure
• Wearable tech and human interfaces

Energy and green technologies

• Biofuels
• Clean air
• Fuel cells and battery technology
• Renewables and recycling
• Solar power
• Water, oil and gas, nuclear, fusion, fission
• Wind turbines

Food and beverage

• Beverages
• Nutrition
• Retail

Industrial manufacturing and processing

• Packaging
• Polymers and plastics
• Printing tech
• Additive manufacturing
• Coatings
• Construction

Materials

• Advanced materials
• Composite materials
• Metallurgy and alloys
• Nanotechnology

Medical devices and diagnostics 

• Artificial intelligence
• Devices
• Diagnostic instruments
• Digital health
• Drug delivery
• Immuno-oncology
• In vitro diagnostics
• Medtech

Pharmaceuticals

• Diagnostics
• Drug delivery
• Generic market entry
• Medicinal chemistry
• Methods of production and synthesis
• Personalised medicine/disease biomarkers
• Pharmaceutical formulations
• Pharmaceuticalsceutical formulations
• Polymorphs
• Small molecule pharmaceuticals
• Supplementary protection certificates (SPCs)

Trade marks

• Consumer goods
• Cosmetics and perfumery
• Financial services
• Mechanical products
• Services
• Telecommunications